USPTO Examiner FERNANDEZ SUSAN EMILY - Art Unit 1651

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18964948Compositions and Methods for Cleaning Contaminated Solids and LiquidsDecember 2024January 2026Abandon1310NoNo
18732797PREPARING LIVE MICROBIAL SAMPLES AND MICROORGANISMS FOR SUBSEQUENT MASS SPECTROMETRIC MEASUREMENT AND EVALUATIONJune 2024December 2025Allow1820YesNo
18672898METHOD FOR DECOMPOSING PERACETIC ACID AND METHOD FOR CULTURING MICROORGANISMS USING SAMEMay 2024October 2025Allow1620NoNo
18597734Non-Toxic Pest Control Compositions and Methods and Uses ThereofMarch 2024February 2025Allow1210YesNo
18422022METHOD FOR REGULATING BLOOD GLUCOSE, LOSING WEIGHT, AND REDUCING PRODUCTION OF ADVANCED GLYCATION END PRODUCTS BY USING SACCHAROMYCES CEREVISIAE TCI907 OR SUPERNATANT THEREOFJanuary 2024August 2025Allow1911YesNo
18568959A METHOD OF CELL LYSISDecember 2023May 2025Allow1710YesNo
18568297MICROALGAE STRAIN CHLORELLA SP. VADA 2020December 2023August 2025Abandon2010NoNo
18514032DIAGNOSTIC AGENT AND MEDICINE COMPRISING ADAMTS13 AS MAIN INGREDIENTNovember 2023August 2025Abandon2120NoNo
18387563BIOLOGICAL-SPECIMEN TRANSPARENTIZING AGENT, SYSTEM, AND USE THEREFORNovember 2023March 2025Abandon1610NoNo
18460092Papermaking Additive Compositions and Methods and Uses ThereofSeptember 2023December 2024Allow1510YesNo
18460056Liquid Bio-Catalytic CompositionSeptember 2023March 2025Allow1810YesNo
18460129Non-Toxic Plant Agent Compositions and Methods and Uses ThereofSeptember 2023March 2025Allow1810YesNo
18273347NOVEL RHIZOPUS OLIGOSPORUS STRAIN AND ANTIMICROBIAL COMPOSITION INCLUDING THE SAMEJuly 2023February 2026Allow3111YesNo
18219581SYNBIOTIC COMPOSITION FOR IMPROVING IMMUNE RESPONSE AND ANTIOXIDANT CAPACITY DURING AGING AND A PROCESS FOR THE PREPARATION THEREOFJuly 2023November 2024Allow1620YesNo
18213528Compositions and Methods for Cleaning Contaminated Solids and LiquidsJune 2023August 2024Allow1310NoNo
18329769Lipid Abnormalities and Association with Atopic Allergic DiseasesJune 2023June 2025Abandon2411NoNo
18246760AUTOMATIC DEVICE FOR NON-INVASIVE MALARIA DIAGNOSIS THROUGH OPTICAL REFLECTANCE TECHNIQUES, METHODS AND USES THEREOFMarch 2023January 2026Abandon3401NoNo
18188038Targeted Protease Compositions and Uses Related TheretoMarch 2023September 2024Allow1810NoNo
18107320METHOD FOR ADMINISTERING UMBILICAL CORD BLOOD OR PERIPHERAL BLOODFebruary 2023June 2025Allow2831YesNo
18157007ISOLATION OF FETAL CELLSJanuary 2023March 2026Abandon3801NoNo
18075699DIAGNOSTIC AGENT AND MEDICINE COMPRISING ADAMTS13 AS MAIN INGREDIENTDecember 2022March 2024Abandon1510NoNo
18061968INTEGRATED SYSTEMS AND METHODS FOR COMBINING METHANOTROPHIC BACTERIAL BIOMASS PRODUCTION AND METHANATION PROCESSDecember 2022September 2025Abandon3311NoNo
17992188BIOCATALYTIC MICROCAPSULES FOR CATALYZING GAS CONVERSIONNovember 2022January 2025Abandon2621NoNo
17925779ANIMAL FEED COMPOSITIONSNovember 2022March 2026Allow4011YesNo
18054664COMPOSITIONS AND METHODS FOR CONTROLLING HEAD BLIGHT DISEASENovember 2022June 2024Abandon1911NoNo
17923863METHOD AND DEVICE FOR INACTIVATING VIRUSNovember 2022November 2025Abandon3601NoNo
17976076NANOSYSTEMS FOR CONTROLLED TRANSPORT OF ACTIVE MOLECULES FOR DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC PURPOSESOctober 2022June 2024Allow1911YesNo
17921951Method And System Of Pre-Treating Biomass, In Particular Biomass That Is Resistant To Cell Disruption, For Improving The Accessibility Of Cellular Compounds TherefromOctober 2022January 2026Abandon3901NoNo
17959215METHOD FOR DETECTING OPIOIDS, OPIATES, CANNABINOIDS, OR BENZODIAZEPINES IN A SAMPLE WITH A B-GLUCURONIDASE ENZYMEOctober 2022March 2025Allow2930YesNo
17937090PROBIOTICS FOR COGNITIVE AND MENTAL HEALTHSeptember 2022October 2025Allow3721YesNo
17932995Wireless Activation of Channelrhodopsin via In Situ Self-assembly of Semiconductor Quantum Dots at the Plasma MembraneSeptember 2022January 2026Allow4011NoNo
17823318PREPARING LIVE MICROBIAL SAMPLES AND MICROORGANISMS FOR SUBSEQUENT MASS SPECTROMETRIC MEASUREMENT AND EVALUATIONAugust 2022April 2024Allow2020YesNo
17796577AGENT FOR MAINTAINING OR ENHANCING COLLAGEN PRODUCTION ABILITYJuly 2022January 2026Abandon4211NoNo
17794926COMPOSITION FOR INFLAMMATORY BOWEL DISEASEJuly 2022September 2025Abandon3810NoNo
17813432METHOD FOR DENITRATION OF FLUE GASJuly 2022March 2024Abandon2010NoNo
17793116Method for Producing Biomass from a MicroalgaeJuly 2022February 2026Allow4321NoNo
17862707HIGH DENSITY DISTRIBUTED THREE-DIMENSIONAL ELECTRODE DEVICEJuly 2022October 2025Allow3910YesNo
17785026BIOSYNTHESIS OF INSECT PHEROMONES AND PRECURSORS THEREOFJune 2022March 2026Abandon4502NoNo
17784654BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS I797, METHOD FOR SEPARATION AND PURIFICATION THEREOF, AND USE THEREOFJune 2022June 2025Abandon3721NoNo
17834221HIGH FREQUENCY APPLICATION OF BOTULINUM TOXIN THERAPYJune 2022January 2026Abandon4420NoNo
17663485CONTIGUITY PARTICLE FORMATION AND METHODS OF USEMay 2022June 2025Allow3740YesNo
17735595METHOD AND PLATFORM FOR DISRUPTING INTRACELLULAR MICROTUBULESMay 2022February 2024Abandon2101NoNo
17292284NOVEL SPIRULINA PLATENSIS STRAINMay 2022October 2024Allow4110YesNo
17767718IMPROVED URICASE AND METHOD FOR TREATING HYPERURICEMIA USING SAMEApril 2022November 2025Abandon4311NoNo
17763178METHOD FOR PRODUCING ASTAXANTHIN BY HETEROTROPHIC CULTURE OF HAEMATOCOCCUS PLUVIALISMarch 2022September 2025Abandon4131NoNo
17762750METHODS OF IDENTIFICATION OF SYNERGISTIC ANTI-CANCER MULTIDRUG COMBINATIONS AND USES THEREOFMarch 2022December 2025Abandon4511NoNo
17686414METHOD FOR PRODUCING A MATERIAL USING COLLAGEN FROM CULTURED ANIMAL CELLSMarch 2022January 2025Abandon3521NoNo
17635115BACTERIAL STRAINS HAVING FUNGICIDAL ACTIVITY, COMPOSITIONS COMPRISING SAME AND USE THEREOFFebruary 2022October 2025Allow4421YesNo
17634818COMPOSITIONS FOR GUT HEALTHFebruary 2022December 2025Allow4611YesNo
17666528MATERIALS AND METHODS FOR TREATING AND EVALUATING ISCHEMIC AND/OR REPERFUSION-INJURED TISSUE AND/OR TISSUE SUSCEPTIBLE TO SAMEFebruary 2022March 2026Abandon4921NoNo
17626632KIT FOR PREDICTING OR DIAGNOSING NONALCOHOLIC FATTY LIVER DISEASE, AND METHOD FOR DIAGNOSING NONALCOHOLIC FATTY LIVER DISEASEJanuary 2022May 2025Abandon4101NoNo
17647655SYSTEM AND METHOD FOR METHANE BIODEGRADATIONJanuary 2022September 2024Abandon3231YesNo
17646978ASPERGILLUS NIGER F22 STRAIN HAVING NEMATICIDAL ACTIVITY AGAINST PLANT-PARASITIC NEMATODES, AND USE THEREOFJanuary 2022December 2023Abandon2310NoNo
17617952METHOD FOR DETERMINING THE EFFECTIVENESS OF A STERILIZATION METHOD FOR A MEDICAL PRODUCT IN A STERILIZER, DATA PROCESSING SYSTEM, COMPUTER PROGRAM PRODUCT, AND MEDICAL PRODUCTDecember 2021September 2025Abandon4611NoNo
17526048METHODS FOR ISOLATING MICROBIAL CELLS FROM A BLOOD SAMPLENovember 2021September 2024Allow3420NoNo
17611337COMPOSITION FOR DUST SUPPRESSIONNovember 2021January 2025Abandon3821NoNo
17511033Mass Spectrometry Ionization Based-Assay For the Detection of Enzyme Activity and/or PresenceOctober 2021January 2024Allow2710YesNo
17446961Non-Toxic Pest Control Compositions and Methods and Uses ThereofSeptember 2021December 2023Allow2720YesNo
17404460METHOD AND APPARATUS FOR THE UTILIZATION OF ZERO FIBER AND OTHER SIDE STREAMSAugust 2021February 2024Abandon3001NoNo
17403314ELECTRON BEAM IRRADIATED OSTEOINDUCTIVE BONE IMPLANTAugust 2021October 2023Allow2620YesNo
17387048MICROBIAL COMPOSITION AND MICROORGANISM-BASED METHOD OF MANUFACTURING AND TREATING OF ANIMAL FARMS USING OF THE SAMEJuly 2021November 2025Allow5151YesNo
17382875AGRICULTURALLY BENEFICIAL MICROBES, MICROBIAL COMPOSITIONS, AND CONSORTIAJuly 2021September 2024Abandon3811NoNo
17369390Method For Dissociation Of CellsJuly 2021June 2025Abandon4730NoNo
17419931METHOD FOR DECOMPOSING PERACETIC ACID AND METHOD FOR CULTURING MICROORGANISMS USING SAMEJune 2021March 2024Allow3311YesNo
17359752CHARACTERIZATION OF MICROORGANISMS VIA MALDI-TOFJune 2021September 2023Abandon2610NoNo
17417236STRAIN PRODUCING ERGOTHIONEINE AND METHOD FOR SCREENING THE SAMEJune 2021December 2025Abandon5441NoNo
17302784METHODS OF USING COSMETIC COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES DERIVED FROM MICROBIAL MATSMay 2021June 2023Allow2510YesNo
17290965HYPOALLERGENIC COMPOSITION FOR SKIN REGENERATION OR SKIN SOOTHING, CONTAINING CULTURE PRODUCT OR EXTRACT OF AUREOBASIDIUM PULLULANS STRAINMay 2021August 2025Allow5130YesNo
17239889SYNTHETIC COMPOSITION FOR PREVENTING OR TREATING CVDApril 2021June 2024Abandon3720YesNo
17288315STRAIN OF CAUCASUS YOGHURT LACTOBACILLUS MSR101 AND USE THEREOFApril 2021July 2023Allow2721YesNo
17234066Rapid Antimicrobial Susceptibility Testing Based on a Unique Spectral Intensity Ratio Analysis via Single Fluorescence Membrane Dye Staining and Flow CytometryApril 2021September 2023Abandon2910NoNo
17229644FOOD COMPOSITION AND PHARMACEUTICAL COMPOSITION USED FOR INCREASING EXERCISE PERFORMANCE AND AMELIORATING FATIGUEApril 2021June 2025Abandon5040NoNo
17159731PROTEIN COMPOSITION AND METHODS FOR ANALYSING MICROBIOTAJanuary 2021January 2024Allow3511YesNo
17150500Compositions and Methods for Cleaning Contaminated Solids and LiquidsJanuary 2021March 2023Allow2610NoNo
17260052SYNBIOTIC COMPOSITION FOR IMPROVING IMMUNE RESPONSE AND ANTIOXIDANT CAPACITY DURING AGING AND A PROCESS FOR THE PREPARATION THEREOFJanuary 2021December 2023Abandon3511NoNo
17135847METHOD FOR ISOLATION AND HARVESTING MICROVESICLESDecember 2020February 2025Abandon4950NoNo
17132496CAPILLARY-BASED SYSTEM FOR ACCELERATED ANTIMICROBIAL SUSCEPTIBILITY TESTINGDecember 2020April 2025Allow5231YesNo
17058689FERMENTATIVE PRODUCTION OF SIALYLATED SACCHARIDESNovember 2020December 2025Allow6021YesNo
17101588Product and Process for Mucus Viscosity NormalizationNovember 2020April 2025Allow5321YesNo
16951870METHOD FOR EMPLOYING CORN PLANT MATERIAL COMPRISING COBS IN THE MANUFACTURE OF ETHANOLNovember 2020May 2023Allow3010YesNo
17053727METHODS AND TOOLS FOR DETERMINING CLONAL RELATEDNESS AND PREDICTING CLONAL TRAITSNovember 2020April 2024Abandon4101NoNo
16948830NOVEL ARTIFICIAL TEARS CONTAINING RECOMBINANT HUMAN LYSOZYMEOctober 2020July 2024Abandon4610NoNo
17034534BETA-LACTAMASE FORMULATIONS AND USES THEREOFSeptember 2020August 2024Allow4720YesNo
17017733METHODS, KITS AND DEVICES FOR MEASURING EXTRACELLULAR PYRIDINE NUCLEOTIDESeptember 2020December 2025Allow6041YesNo
17012828PATHOGENIC BACTERIA AND METHOD FOR DEGRADING ETHYLENE OXIDESeptember 2020March 2022Abandon1821NoNo
16999725METHOD OF MICROBIAL ENHANCED OIL RECOVERY BY CHANGING MICROBIAL MOTILITYAugust 2020June 2021Allow1011YesNo
16993280SACCHAROMYCES CEREVISIAE TCI907, COMPOSITION AND METHOD FOR REGULATING BLOOD GLUCOSE, LOSING WEIGHT AND REDUCING PRODUCTION OF ADVANCED GLYCATION END PRODUCTSAugust 2020June 2024Abandon4631NoNo
16968125CARDIOMYOCYTE PROLIFERATION PROMOTING AGENT AND USE THEREOFAugust 2020March 2024Abandon4301NoNo
16965760Method and Apparatus for Continuous Production of SophorolipidsJuly 2020September 2024Abandon5011NoNo
16954590PROBIOTICS FOR COGNITIVE AND MENTAL HEALTHJune 2020November 2022Abandon2911NoNo
16768327ISOLATION AND PURE CULTURE OF AN ARCHAEBACTERIUM OF ORDER METHANOMASSILIICOCCALESMay 2020September 2022Allow2811YesNo
16886791MYROIDES ODORATIMIMUS BIOCONTROL STRAIN FOR EFFICIENTLY DEGRADING AFLATOXIN AND APPLICATION THEREOFMay 2020December 2022Allow3011YesNo
16841599ANTI-VIRAL THERAPEUTIC FOR INFECTION OF THE EYEApril 2020June 2024Abandon5130NoNo
16832824Systems and Methods for Metabolic Assessment Utilizing 1-Methoxy-PMS FieldMarch 2020May 2025Abandon6041NoNo
16826261HYPERTHERMOPHILIC AEROBIC FERMENTATION INOCULANT PREPARED BY USING MUNICIPAL SEWAGE SLUDGE AND ITS METHODMarch 2020July 2023Allow4020NoNo
16822698PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF TO TREAT PANCREATIC ENZYME INSUFFICIENCYMarch 2020January 2023Abandon3401NoNo
16647396MULTIPLEXED PROTEIN ASSAY FOR THE DETECTION OF MITOCHONDRIAL PROTEIN SIGNATURESMarch 2020October 2025Allow6041YesNo
16797172STRAINS OF BACILLUS FOR INHIBITING FOODBORNE PATHOGENSFebruary 2020February 2024Allow4831YesNo
16787595ANTIGEN PROTECTION METHOD FOR ENABLING DELAYED SAMPLE PROCESSINGFebruary 2020October 2024Allow5731NoNo
16785396FLUID SEPARATION SYSTEM AND METHOD WHICH USES MAGNETIC PARTICLESFebruary 2020March 2025Allow6031YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FERNANDEZ, SUSAN EMILY.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
12
Examiner Affirmed
7
(58.3%)
Examiner Reversed
5
(41.7%)
Reversal Percentile
64.0%
Higher than average

What This Means

With a 41.7% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
87
Allowed After Appeal Filing
23
(26.4%)
Not Allowed After Appeal Filing
64
(73.6%)
Filing Benefit Percentile
38.4%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 26.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner FERNANDEZ, SUSAN EMILY - Prosecution Strategy Guide

Executive Summary

Examiner FERNANDEZ, SUSAN EMILY works in Art Unit 1651 and has examined 750 patent applications in our dataset. With an allowance rate of 46.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 41 months.

Allowance Patterns

Examiner FERNANDEZ, SUSAN EMILY's allowance rate of 46.0% places them in the 10% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by FERNANDEZ, SUSAN EMILY receive 2.54 office actions before reaching final disposition. This places the examiner in the 74% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by FERNANDEZ, SUSAN EMILY is 41 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +56.8% benefit to allowance rate for applications examined by FERNANDEZ, SUSAN EMILY. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 16.9% of applications are subsequently allowed. This success rate is in the 14% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 30.1% of cases where such amendments are filed. This entry rate is in the 43% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 94.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 69% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 80.0% of appeals filed. This is in the 71% percentile among all examiners. Of these withdrawals, 60.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 69.6% are granted (fully or in part). This grant rate is in the 77% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 5.6% of allowed cases (in the 87% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.